Newsletter
Every new paper in this field, in your inbox.
Elevated levels of bile-derived cfDNA markers, syncytin-1 and SLC7A11, were identified in cholangiocarcinoma patients compared to those with gallstones, demonstrating significant potential for early diagnosis. Researchers noted an area under the curve (AUC) of 0.805 for syncytin-1 and 0.755 for SLC7A11, indicating robust specificity, while…
TEAD1 expression correlates with liver regeneration outcomes in patients undergoing ALPPS, a two-stage surgical procedure. Analysis of tumor-free liver tissue from 44 patients reveals that nuclear and cytoplasmic scores of TEAD1 serve as predictive markers for clinical outcomes. The study also notes that TEAD family…
A systematic review and meta-analysis evaluated minimally invasive associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) compared to open methods. Findings revealed a significant reduction in 90-day mortality (risk ratio = 0.48) and overall length of hospital stay (mean difference = -8…
A predictive model for identifying intrahepatic collateral vessels in patients with caval confluence tumors reveals that 78% exhibited such vessels. Out of those, 92% underwent parenchyma-sparing hepatectomies, with zero operative mortality and no liver congestion reported. The study established tumor size, number, hepatic vein infiltration,…
A prospective study of 56 colorectal cancer patients reveals that preoperative circulating tumor DNA (meth-ctDNA) serves as a significant biomarker for assessing treatment plans. Negative preoperative meth-ctDNA correlates with longer median progression-free survival (PFS), identified as a strong independent predictor (HR=3.3). Similarly, negative postoperative meth-ctDNA…
Between 1990 and 2021, gallbladder and biliary tract cancer (GBTC) saw a substantial increase, with new cases rising by 101.09% and deaths by 74.26%. In 2021, there were approximately 216,768 new cases and 171,961 deaths globally, predominantly affecting females and older adults. Although age-standardized incidence…
A study of seventy patients undergoing EUS-guided drainage revealed that 35.7% required step-up procedures, mainly endoscopic necrosectomy. Independent predictors included necrosis ≥60% and classification in the high-risk Quadrant Necrosis Infection (QNI) group. Clinical success was high, at 92.9%, with those in the high-risk group experiencing…
A Phase II trial demonstrated that combining irreversible electroporation (IRE) with β-glucan significantly improved disease-free intervals and overall survival in patients with stage III pancreatic ductal adenocarcinoma. The study included 30 patients treated with IRE followed by β-glucan, showing a median disease-free interval of 18…
Observational data indicate that pancreatic resections for neuroendocrine tumors (pnet) result in a significantly lower rate of ideal outcomes compared to pancreatic ductal adenocarcinoma (pdac) patients. The ideal outcome rate was 47.7% for pnet versus 55.7% for pdac, primarily due to a fourfold increase in…
A novel EUS-guided technique utilizing lumen-apposing metal stents effectively treated patients with concomitant gastric outlet and biliary obstructions. In a study involving nine severely ill individuals, complete resolution of jaundice was achieved in all cases, attributed to successful transduodenal ERCP via gastroduodenal stenting. Post-procedure evaluations…
